Serum Institute to introduce Novavax’s vaccine in India by September

INDIA – The Indian government through the Serum Institute of India (SII) is planning to introduce an Indian version of Covavax originally formulated by a US based biotech company, Novavax Inc. Clinical trials are underway in India and the vaccine is likely to hit the market under the name Covavax by September this year though clinical trials on children are expected to kick-off from July. The vaccine is among the first to have undergone phase 3 clinical trials at a time when new Covid-19 variants of concern such as the…

Read More

Indian government to avail 120 million doses of COVID vaccine to bolster fight against C0VID-19

INDIA – Indian government has announced 120 million doses of COVID vaccine will be availed for use in the month of June to help mitigate the COVID situation in the country. This is an upscale from 79.4 million doses that were available in May for public inoculation in the Southern Asia country. According to the Indian government, 60.9 million doses will be made available by the central government to states for vaccination of healthcare and frontline workers and those above the age of 45 years, while 58.6 million doses will…

Read More

UNICEF secures long-term supply of Sputnik V COVID-19 vaccine

RUSSIA – UNICEF has entered an agreement with Russian Direct Investment fund(RDIF), through its wholly owned subsidiary, Human Vaccine, for a supply of 220 million doses of Sputnik V vaccine. This agreement which is conditional on the product achieving an Emergency Use Listing from WHO, will see a total of 110 million people get immunized. UNICEF has also signed three other similar agreements with COVID-19 manufactures Serum Institute of India, Pfizer, and AstraZeneca in a bid to meet vaccine demand across the globe. Earlier, Moderna committed to supply 34 million…

Read More